Amphetamine Sulfate Patent Expiration
Amphetamine Sulfate is Used for treating Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients. It was first introduced by Azurity Pharmaceuticals Inc
Amphetamine Sulfate Patents
Given below is the list of patents protecting Amphetamine Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Evekeo Odt | US10441554 | Oral amphetamine composition | Mar 10, 2037 | Azurity |
| Evekeo Odt | US11160772 | Oral amphetamine composition | Mar 10, 2037 | Azurity |
| Evekeo Odt | US11896562 | Oral amphetamine composition | Mar 10, 2037 | Azurity |
| Evekeo Odt | US10130580 | Taste-masked pharmaceutical compositions |
Apr 19, 2024
(Expired) | Azurity |
Amphetamine Sulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List